Teva Hit With Class-action Suit by Shareholders in NY Court

Lawsuit claims firm's stock price was inflated because executives failed to disclose conflicts between management and the board.

Yoram Gabison
Yoram Gabison
Send in e-mailSend in e-mail
Yoram Gabison
Yoram Gabison

Comments